Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 12, 2021
Clinical significance of heart rate variability for the monitoring of cardiac autonomic neuropathy in end-stage renal disease patientsJi Won Min, Ji-Yeun Chang, Hanbi Lee, et al.Annals of Laboratory Medicine|February 27, 2023
Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant RecipientsHaeun Lee, Hanbi Lee, Sang Hun Eum, et al.Kidney Research and Clinical Practice|February 20, 2025
Clinical outcomes of bortezomib-based desensitization in highly sensitized living and deceased donor kidney transplantationHyeran Park, Hanbi Lee, Sang Hun Eum, et al.Medicine|March 18, 2016
Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant RecipientsHyeyoung Lee, Ji Won Min, Ji-Il Kim, et al.Journal of Clinical Medicine|January 10, 2026
Combined Impact of Mean and Variability of Non-HDL Cholesterol on Myocardial Infarction in Hemodialysis PatientsHanbi Lee, Ji Won Min, Tae Hyun Ban, et al.International Journal of Molecular Sciences|July 9, 2022
Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant RecipientsHyeyoung Lee, Ji Won Min, Hyunhye Kang, et al.American Journal of Respiratory and Critical Care Medicine|November 19, 2005
Complement C3a and C4a increased in plasma of patients with aspirin-induced asthmaSeung-Ha Lee, Taiyoun Rhim, Yun-Sung Choi, et al.Journal of Korean Medical Science|December 9, 2025
Long-Term Clinical Outcomes of ABO-Incompatible Kidney Transplantation in Patients With High Baseline Anti-A/B Antibody TitersSang Hun Eum, Hanbi Lee, Eun Jeong Ko, et al.Journal of Human Genetics|March 4, 2005
Association of eotaxin-2 gene polymorphisms with plasma eotaxin-2 concentrationJi-Won Min, June-Hyuk Lee, Choon-Sik Park, et al.International Journal of Molecular Sciences|February 10, 2024
Combined Use of Tocilizumab and Mesenchymal Stem Cells Attenuate the Development of an Anti-HLA-A2.1 Antibody in a Highly Sensitized Mouse ModelXianying Fang, Sheng Cui, Hanbi Lee, et al.Pageof 6